Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-3 and hematopoiesis.

J N Ihle1

  • 1Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, Tenn.

Chemical Immunology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Interleukin-3 (IL-3) supports hematopoietic cell proliferation and differentiation, showing promise in clinical trials for conditions like aplastic anemia. Its role in immune responses and differentiation pathways is still being defined.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription.

The EMBO journal·2001
Same author

Variations in the human phospholipase Cgamma2 gene in patients with B-cell defects of unknown etiology.

Immunogenetics·2001
Same author

Membrane localization is not required for Mpl function in normal hematopoietic cells.

Blood·2001
Same author

Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT/enhancer-binding protein epsilon.

Blood·2001
Same author

The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis.

The EMBO journal·2001
Same author

Gadd45gamma is dispensable for normal mouse development and T-cell proliferation.

Molecular and cellular biology·2001

Area of Science:

  • Hematology
  • Immunology
  • Cell Biology

Background:

  • Interleukin-3 (IL-3) is known for its role in supporting the proliferation and differentiation of various hematopoietic cells.
  • Clinical trials are exploring IL-3's therapeutic potential, particularly for conditions benefiting from myeloid progenitor expansion.

Purpose of the Study:

  • To investigate the biological activities and therapeutic potential of Interleukin-3 (IL-3).
  • To explore the role of IL-3 in hematopoiesis, immune responses, and cell differentiation pathways.

Main Methods:

  • Review of accumulated biological data on IL-3.
  • Analysis of ongoing clinical trials involving IL-3.
  • Hypothetical modeling of IL-3's influence on differentiation programs.

Related Experiment Videos

Main Results:

  • IL-3 demonstrates a unique capacity to support a broad spectrum of hematopoietic cells.
  • IL-3 holds promise for conditions like aplastic anemias and post-chemotherapy recovery.
  • Evidence suggests hematopoiesis is not solely dependent on IL-3, implying alternative factors exist.

Conclusions:

  • IL-3's pleiotropic activity warrants further clinical investigation.
  • IL-3 may function as a mechanism for immune reactions to influence hematopoiesis.
  • IL-3 likely influences, rather than solely controls, differentiation outcomes.